RNWL
INTERNATIONAL REGISTRATION RENEWED
06/08/2026
Voltar para busca
Dado oficial do USPTO
CSL
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
68
Atualização mais recente
06/08/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
16, 40
Data de depósito
21/08/2006
Data de registro
20/11/2007
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
19/01/2018
Última transação
06/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
707
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
11
Localização do titular
AU
Examinador
DELANEY, ZHALEH SYBIL
Unidade examinadora
M70
Titulares e representantes
Titulares
CSL Limited
Representantes
Scott D. Woldow Smith, Gambrell & Russell, LLP
Classificação técnica
Classes Nice
Classe 16Classe 40
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 16
Printed matter and publicationsprinted instructional material and magazines featuring pharmaceutical productsvaccinesbloodblood productsbleeding disordersblood fractionationsrhesus prophylaxis and human autoimmune disorders ; printed instructional and teaching materials in the field of pharmaceutical productsvaccinesbloodblood productsbleeding disordersblood fractionationsrhesus prophylaxis and human autoimmune disorders; brochurespamphlets and informational flyers in the field of pharmaceutical productsvaccinesbloodblood productsbleeding disordersblood fractionationsrhesus prophylaxis and human autoimmune disorders; posters; stationery
Classe 40
Treatment of biological productscustom manufacturing and fractionation of blood
Publicações
Histórico de despachos e eventos da marca no USPTO.
68 publicações encontradas
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
31/03/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/10/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/10/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/10/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/10/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/10/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/10/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
29/08/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
29/08/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
29/08/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
29/08/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
29/08/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
29/08/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17/12/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17/12/2018
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
26/10/2018
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
20/09/2018
INPC
INVALIDATION PROCESSED
20/09/2018
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
19/09/2018
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
19/01/2018
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
19/01/2018
ES71
TEAS SECTION 71 RECEIVED
17/01/2018
NREP
NEW REPRESENTATIVE AT IB RECEIVED
27/07/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
18/05/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/02/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
16/12/2016
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
20/11/2016
RNWL
INTERNATIONAL REGISTRATION RENEWED
15/09/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/07/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/07/2016
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
03/02/2014
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
03/02/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
31/01/2014
715F
REGISTERED - SEC. 71 & SEC. 15 FILED
14/01/2014
ES75
TEAS SECTION 71 & 15 RECEIVED
14/01/2014
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
20/09/2011
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/06/2009
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
02/04/2009
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
02/04/2009
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
19/03/2009
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
05/03/2009
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/03/2008
FIMP
FINAL DISPOSITION PROCESSED
03/03/2008
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
20/02/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
20/11/2007
PUBO
PUBLISHED FOR OPPOSITION
04/09/2007
NPUB
NOTICE OF PUBLICATION
15/08/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
24/05/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/05/2007
XAEC
EXAMINER'S AMENDMENT ENTERED
22/05/2007
GNEA
EXAMINERS AMENDMENT E-MAILED
22/05/2007
CNEA
EXAMINERS AMENDMENT -WRITTEN
22/05/2007
ACEC
AMENDMENT FROM APPLICANT ENTERED
14/05/2007
ALIE
ASSIGNED TO LIE
14/05/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/04/2007
PAPER RECEIVED
20/04/2007
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/03/2007
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/03/2007
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/03/2007
RFNT
REFUSAL PROCESSED BY IB
08/12/2006
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
22/11/2006
RFRR
REFUSAL PROCESSED BY MPU
22/11/2006
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
21/11/2006
CNRT
NON-FINAL ACTION WRITTEN
20/11/2006
DOCK
ASSIGNED TO EXAMINER
16/11/2006
NWAP
NEW APPLICATION ENTERED
27/10/2006
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
26/10/2006
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CSL ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.